Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease

Summary

This study proposes to evaluate clinical outcomes and viral load in COVID-19 infected patients with early moderate and severe disease admitted to the hospital and randomized to one of three arms. Patients will be randomized to supportive care, OR hydroxychloroquine alone, OR hydroxychloroquine and azithromycin.

Timeline

Start

2020-04-13

Primary completion

2021-04-10

Completion

2022-01-05

Drugs

Indications